At Current Prices GLP-1s Aren t Cost-Effective, Limiting Access To Patients

Get the Full StoryGLP-1s can deliver value to patients. But the fact that GLP-1s aren't cost-effective at their current net prices can limit insurer coverage and prevent equitable access.

Share: